Hypertransfusion therapy in sickle cell disease in Nigeria

Advances in Hematology

Volumn 2014, Issue , 2014, Pages

  Adewoyin, Ademola Samson ^a   Obieche, Jude Chike ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN S;

AIR EMBOLISM; ALLERGIC REACTION; ALLOIMMUNIZATION; ANAPHYLAXIS; BACTERIUM CONTAMINATION; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CEREBROVASCULAR ACCIDENT; CITRIC ACID TOXICITY; COMMUNICABLE DISEASE; ECHOGRAPHY; ERYTHROCYTE TRANSFUSION; FEBRILE NONHEMOLYTIC TRANSFUSION REACTION; HEALTH STATUS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERKALEMIA; HYPERTRANSFUSION; HYPOCALCEMIA; HYPOTHERMIA; IMMUNOMODULATION; IRON OVERLOAD; MEDLINE; NIGERIA; PATIENT SELECTION; PRIORITY JOURNAL; PURPURA; REVIEW; SICKLE CELL ANEMIA; THROMBOPHLEBITIS; TOXICITY; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION MEDICINE; TRANSFUSION RELATED ACUTE LUNG INJURY; URTICARIA;

EID: 84922389567     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2014/923593     Document Type: Review

References (68)

1. D. J. Weatherall and J. B. Clegg, "Inherited haemoglobin disorders: An increasing global health problem," Bulletin of the World Health Organization, vol. 79, no. 8, pp. 704-712, 2001.
2. B. Modell and M. Darlison, "Global epidemiology of haemoglobin disorders and derived service indicators," Bulletin of the World Health Organization, vol. 86, no. 6, pp. 480-487, 2008.
3. WHO Regional Office for Africa, "Sickle cell disease prevention and control," November 2013, http://www.afro.who.int/en/nigeria/nigeria-publications/1775-sickle%20cell%20disease.html.
4. G. R. Serjeant and B. E. Sergent, "The epidemiology of sickle cell disorder: A challenge for Africa," Archives of Ibadan Medicine, vol. 2, no. 2, pp. 4-52, 2001.
5. A. L.Okwi,W.Byarugaba,C.M.Ndugwa, A. Parkes,M.Ocaido, and J. K. Tumwine, "An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda," BMC Blood Disorders, vol. 10, article 5, 2010.
6. B. Nwogoh, A. S. Adewoyin, O. E. Iheanacho, and G. N. Bazuaye, "Prevalence of haemoglobin variants in Benin City, Nigeria," Annals of Biomedical Sciences, vol. 11, no. 2, pp. 60-64, 2012.
7. S. D. Grosse, I. Odame, H. K. Atrash, D. D. Amendah, F. B. Piel, and T. N. Williams, "Sickle cell disease in Africa: A neglected cause of early childhood mortality," American Journal of Preventive Medicine, vol. 41, no. 6, supplement 4, pp. S398-S405, 2011.
8. J. Makani, T. N. Williams, and K. Marsh, "Sickle cell disease in Africa: Burden and research priorities," Annals of Tropical Medicine and Parasitology, vol. 101, no. 1, pp. 3-14, 2007.
9. M. Brozovic and S. Davies, "Management of sickle cell disease," PostgraduateMedical Journal, vol. 63,no. 742, pp. 605-609, 1987.
10. "Sickle Cell Anaemia. Agenda item 11.4," in Proceedings of the 59th World Health Assembly, Geneva, Switzerland, May 2006, http://www.who.int/gb/ebwha/pdf files/WHA59-REC1/WHA59 2006 REC1-en.pdf.
11. F. A. Olatona, K. A. Odeyemi, A. T. Onajole, and M. C. Asuzu, "Effects of health education on knowledge and attitude of youth corps members to sickle cell disease and its screening in Lagos State," Journal of CommunityMedicine & Health Education, vol. 2, no. 7, article 163, 2012.
12. R. S. Owolabi, P. Alabi, D. Olusoji, S. Ajayi, T. Otu, and A. Ogundiran, "Knowledge and attitudes of secondary school students in Federal Capital Territory, Abuja, Nigeria towards sickle cell disease," Nigerian Journal of Medicine, vol. 20, no. 4, pp. 479-485, 2011.
13. S. Abubakar,U.M.Lawan,M.S.Mijinyawa, S. I. Adeleke, andH. Sabiu, "Perceptions about sickle cell disease and its prevention among undergraduates of tertiary institutions in Kano State, Nigeria," Nigerian Journal of ClinicalMedicine, vol. 3, no. 1, 2010.
14. G. N. Bazuaye and E. E. Olayemi, "Knowledge and attitude of senior secondary school students in Benin CityNigeria to sickle cell disease,"World Journal of Medical Sciences, vol. 4, no. 1, pp. 46-49, 2009.
15. D. A. Adekanle and A. S. Adeyemi, "Prevention of Sickle cell disease by prenatal diagnosis-opinion of female health workers in Osogbo, South-Western Nigeria," Ibom Medical Journal, vol. 2, no. 1, pp. 20-22, 1997.
16. M. A. Durosinmi, A. I. Odebiyi, I. A. Adediran, N. O. Akinola, D. E.Adegorioye, and M. A. Okunade, "Acceptability of prenatal diagnosis of sickle cell anaemia (SCA) by female patients and parents of SCA patients in Nigeria," Social Science & Medicine, vol. 41, no. 3, pp. 433-436, 1995.
17. N.Win, "Blood transfusion therapy for Haemoglobinopathies," in Practical Management of Haemoglobinopathies, I. E. Okpala, Ed., pp. 99-106, Blackwell Publishing, 2004.
18. G. R. Serjeant, "Chronic transfusion programmes in sickle cell disease: Problem or panacea?" British Journal of Haematology, vol. 97, no. 2, pp. 253-255, 1997.
19. M. F. Murphy, T. B. Wallington, P. Kelsey et al., "Guidelines for the clinical use of red cell transfusions," British Journal of Haematology, vol. 113, no. 1, pp. 24-31, 2001.
20. G. Liumbruno, F. Bennardello, A. Lattanzio, P. Piccoli, and G. Rossetti, "Recommendations for the transfusion of red blood cells," Blood Transfusion, vol. 7, no. 1, pp. 49-64, 2009.
21. J. Pendergrast, "Transfusion of Patients with Thalassemia and Sickle Cell Disease," https://www.lhsc.on.ca/lab/bldbank/assets/LLSGSymposium11/Pendergrast%202011%5B1%5D.pdf.
22. K. Natarajan, "Disorders of haemoglobin structure: Sickle cell anaemia and related abnormalities," in Williams Haematology, M.A. Lichtman, Ed., vol. 47, pp. 667-700, McGraw-Hill, 2006.
23. S. Charache, "The treatment of sickle cell anemia," Archives of Internal Medicine, vol. 133, no. 4, pp. 698-705, 1974.
24. M. J. Telen, "Principles and problems of transfusion in sickle cell disease," Seminars inHematology, vol. 38, no. 4, pp. 315-323, 2001.
25. M. Koshy, L. Burd, D. Wallace, A. Moawad, and J. Baron, "Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study," The New England Journal ofMedicine, vol. 319, no. 22, pp. 1447-1452, 1988.
26. S. Laulan, J. F. Bernard, and P. Boivin, "Systematic blood transfusions in adult homozygous sicle-cell anaemia," Presse Medicale, vol. 19, no. 17, pp. 785-789, 1990.
27. A. R. Cohen, M. B. Martin, J. H. Silber, H. C. Kim, K. Ohene-Frempong, and E. Schwartz, "A modified transfusion program for prevention of stroke in sickle cell disease," Blood, vol. 79, no. 7, pp. 1657-1661, 1992.
28. M. T. Lee, S. Piomelli, S. Granger et al., "Stroke prevention Trial in Sickle Cell Anaemia (STOP): Extended Follow up and final results," Blood, vol. 108, no. 3, pp. 847-852, 2006.
29. W. F. Rosse, M. Narla, L. D. Petz, and M. H. Steinberg, "New views of sickle cell disease pathophysiology and treatment," in American Society ofHaematology Education Book, vol. 2000, pp. 2-17, 2000.
30. D. C. Rees, T. N. Williams, and M. T. Gladwin, "Sickle-cell disease," The Lancet, vol. 376, no. 9757, pp. 2018-2031, 2010.
31. G. R. Serjeant, B. E. Serjeant, and P. F. Milner, "The irreversibly sickled cell; a determinant of haemolysis in sickle cell anaemia," British Journal of Haematology, vol. 17, no. 6, pp. 527-533, 1969.
32. W. M. Lande, D. L. Andrews, M. R. Clark et al., "The incidence of painful crisis in homozygous sickle cell disease: Correlation with red cell deformability," Blood, vol. 72, no. 6, 1988.
33. Z. Y. Aliyu, A. R. Tumblin, and G. J. Kato, "Current therapy of sickle cell disease," Haematologica, vol. 91, no. 1, pp. 7-10, 2006.
34. A. S. Wayne, S. V. Kevy, and D. G. Nathan, "Transfusion management of sickle cell disease," Blood, vol. 81,no. 5, pp. 1109-1123, 1993.
35. M. H. Steinberg, "Management of sickle cell disease," The New England Journal ofMedicine, vol. 340, no. 13, pp. 1021-1030, 1999.
36. E. P. Vinchinsky, "Transfusion therapy in sickle cell disease," http://sickle.bwh.harvard.edu/transfusion.html.
37. R. Adams, V. McKie, F. Nichols et al., "The use of transcranial ultrasonography to predict stroke in sickle cell disease,"TheNew England Journal of Medicine, vol. 326, no. 9, pp. 605-610, 1992.
38. R. J. Adams, V. C. McKie, L. Hsu et al., "Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranialDoppler ultrasonography,"The New England Journal of Medicine, vol. 339, pp. 5-11, 1998.
39. S. T. Miller, E. Wright, M. Abboud et al., "Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia," Journal of Pediatrics, vol. 139, no. 6, pp. 785-789, 2001.
40. Z. R. Rogers, "Review: Clinical transfusion management in sickle cell disease," Immunohematology, vol. 22, no. 3, pp. 126-131, 2006.
41. Sickle Cell Disease in Childhood, Standards and Guidelines for Cliinical Care, NHS Sickle Cell and Thalassaemia Screening Programme, London, UK, 2nd edition, 2010.
42. H. H. Al-Saeed and A. H. Al-Salem, "Principles of blood transfusion in sickle cell anemia," SaudiMedical Journal, vol. 23, no. 12, pp. 1443-1448, 2002.
43. Sickle cell society, Standards for the clinical care of adults with sickle cell disease in the United Kingdom, Chapter 6: Blood transfusion 2008.
44. W. H. Zinkham, A. J. Seidler, and T. S. Kickler, "Variable degrees of suppression of hemoglobin S synthesis in subjects with hemoglobin SS disease on a long-term transfusion regimen," Journal of Pediatrics, vol. 124, no. 2, pp. 215-219, 1994.
45. H. Qureshi, Red Cell Transfusion in Sickle Cell Disease, University Hospital of Leicester NHS Trust, 2010.
46. B.A.Gwalam,M.M. Bowdo, A. I.Dutse, andA.Kaliya-Gwarzo, "Patterns of acute blood transfusion reactions in Kano, northwesternNigeria," Nigerian Journal of Basic and Clinical Sciences, vol. 9, pp. 27-32, 2012.
47. O. P. Arewa, N. O. Akinola, and L. Salawu, "Blood transfusion reactions: Evaluation of 462 transfusions at a tertiary hospital in Nigeria," African Journal of Medicine and Medical Sciences, vol. 38, no. 2, pp. 143-148, 2009.
48. J. O. Adewuyi, "Blood group serology," in Companion to Practical Haematology, vol. 10, pp. 74-84, 2007.
49. L. A. M. Bashawri, "Red cell alloimmunization in sickle-cell anaemia patients," Eastern Mediterranean Health Journal, vol. 13, no. 5, pp. 1181-1189, 2007.
50. K.Yazdanbakhsh, R. E.Ware, andF.Noizat-Pirenne, "Redblood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management," Blood, vol. 120, no. 3, pp. 528-537, 2012.
51. Mid-Atlantic Sickle Cell Disease Consortium(MASCC)Guidelines, "Chronic transfusion in children with sickle cell disease," Sickle cell disease in children and adolescents: Diagnosis, guidelines for comprehensive care and protocols for management of acute and chronic complications, 2001.
52. I. A. Shulman, "Prophylactic phenotype matching of donors for the transfusion of nonalloimmunized patients with sickle cell disease," Immunohematology, vol. 22, no. 3, pp. 101-102, 2006.
53. E. P. Vichinsky, A. Earles, R. A. Johnson, M. S. Hoag, A. Williams, and B. Lubin, "Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood," The New England Journal of Medicine, vol. 322, no. 23, pp. 1617-1621, 1990.
54. D. R. Ambruso, J. H. Githens, R. Alcorn et al., "Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy," Transfusion, vol. 27, no. 1, pp. 94-98, 1987.
55. E. P. Vichinsky, N. L. C. Luban, E. Wright et al., "Prospective RBC phenotype matching ina stroke-Prevention trial in sickle cell anemia: Amulticenter transfusion trial," Transfusion, vol. 41, no. 9, pp. 1086-1092, 2001.
56. S. T. Chou, T. Jackson, S. Vege, K. Smith-Whitley, D. F. Friedman, and C. M. Westhoff, "High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors," Blood, vol. 122, no. 6, pp. 1062-1071, 2013.
57. A. R. Cohen, G. R. Buchanan, M. Martin, and K. Ohene-Frempong, "Increased blood requirements during long-term transfusion therapy for sickle cell disease," Journal of Pediatrics, vol. 118, no. 3, pp. 405-407, 1991.
58. B. Otaigbe, "Prevalence of blood transfusion in sickle cell anaemia patients in South-South Nigeria: A two-year experience," International Journal of Medicine and Medical Science Research, vol. 1, no. 1, pp. 13-18, 2013.
59. O.Oniyangi, P. Ahmed, O. T. Otuneye et al., "Strokes inchildren with sickle cell disease at theNationalHospital, Abuja, Nigeria," Nigerian Journal of Paediatrics, vol. 40, no. 2, pp. 158-164, 2013.
60. A. O. Emeribe, A. O. Ejele, E. E. Attai, and E. A. Usanga, "Blood donation and patterns of use in southeastern Nigeria," Transfusion, vol. 33, no. 4, pp. 330-332, 1993.
61. S. G. Ahmed, U. A. Ibrahim, and A. W. Hassan, "Adequacy and pattern of blood donations in North-eastern Nigeria: The implications for blood safety," Annals of Tropical Medicine and Parasitology, vol. 101, no. 8, pp. 725-731, 2007.
62. E. U. Ejeliogu, S. N. Okolo, S. D. Pam et al., "Is human immunodeficiency virus still transmissible through blood transfusion in children with Sickle cell anaemia in Jos, Nigeria?" British Journal of Medicine and Medical Research, vol. 4, no. 21, pp. 3912-3923, 2014.
63. A. I. Lagunju, B. J. Brown, and O. O. Sodeinde, "Chronic Blood transfusion for primary and secondary stroke prevention in Nigerian children with Sickle cell disease: A five year appraisal," Pediatric Blood and Cancer, vol. 60, no. 12, pp. 1940-1945, 2013.
64. K.W. Chan, "Haemopoeitic stem cell transplantation for sickle cell disease: More options and many unanswered questions," Journal of Blood Disorders & Transfusion, vol. 4, p. e106, 2013.
65. M. J. Stuart and R. L.Nagel, "Sickle-cell disease,"TheLancet, vol. 364, no. 9442, pp. 1343-1360, 2004.
66. M. H. Steinberg, "Hydroxyurea treatment for sickle cell disease.," TheScientificWorldJournal, vol. 2, pp. 1706-1728, 2002.
67. R. E.Ware and B. Aygun, "Advances in the use of hydroxyurea," Hematology, pp. 62-69, 2009.
68. S. C. Davies and A. Gilmore, "The role of hydroxyurea in the management of sickle cell disease," Blood Reviews, vol. 17, no. 2, pp. 99-109, 2003.